Risk ReductionRecent exclusion in the national tender of finished Chinese medicines indicates lower risk on price cut for its key product uremic clearance granule (UCG) in the next 2 years.

Bears Say

Economic ImpactSales volume growth slowdown due to a slowing economy.

Consun Pharmaceutical Group Ltd. News

Consun Pharmaceutical Group Announces Upcoming Board Meeting to Discuss Interim Results

Consun Pharmaceutical Group Ltd. ( ($HK:1681) ) has provided an update. Consun Pharmaceutical Group Ltd. has scheduled a...

4d ago

Consun Pharmaceutical Group Engages in Significant Wealth Management Subscriptions

Consun Pharmaceutical Group Ltd. ( ($HK:1681) ) has shared an update. Consun Pharmaceutical Group Ltd. has announced that...

5d ago

Consun Pharmaceutical Group Announces Board Composition and Committee Roles

Consun Pharmaceutical Group Ltd. ( ($HK:1681) ) has provided an update. Consun Pharmaceutical Group Ltd. has announced the...

2M ago

Consun Pharmaceutical Group Ltd. Forms Nomination Committee to Strengthen Governance

The latest announcement is out from Consun Pharmaceutical Group Ltd. ( ($HK:1681) ). Consun Pharmaceutical Group Ltd. has...

2M ago

Consun Pharmaceutical Group Updates Nomination Committee for Enhanced Governance

An update from Consun Pharmaceutical Group Ltd. ( ($HK:1681) ) is now available. Consun Pharmaceutical Group Ltd. announced...

2M ago

Consun Pharmaceutical Launches HKD200 Million Share Repurchase Program

Consun Pharmaceutical Group Ltd. ( ($HK:1681) ) has provided an update. Consun Pharmaceutical Group Ltd. has announced a...

2M ago

Consun Pharmaceutical Successfully Passes AGM Resolutions

Consun Pharmaceutical Group Ltd. ( ($HK:1681) ) just unveiled an announcement. Consun Pharmaceutical Group Ltd. announced the successful...

3M ago

Consun Pharmaceutical’s Traditional Chinese Medicine Product Gains Protected Status

Consun Pharmaceutical Group Ltd. ( ($HK:1681) ) has issued an update. Consun Pharmaceutical Group Ltd. announced that its...

3M ago

Consun Pharmaceutical Gains Approval for SK-09 Tablet Clinical Trials

The latest update is out from Consun Pharmaceutical Group Ltd. ( ($HK:1681) ). Consun Pharmaceutical Group Ltd. has...

4M ago

Consun Pharmaceutical Group Ltd. Announces New Director Appointments

Consun Pharmaceutical Group Ltd. ( ($HK:1681) ) has issued an update. Consun Pharmaceutical Group Ltd. has announced the...

4M ago

1681 FAQ

What was Consun Pharmaceutical Group Ltd.’s price range in the past 12 months?

Consun Pharmaceutical Group Ltd. lowest stock price was HK$5.26 and its highest was HK$13.82 in the past 12 months.

What is Consun Pharmaceutical Group Ltd.’s market cap?

Consun Pharmaceutical Group Ltd.’s market cap is €11.12B.

When is Consun Pharmaceutical Group Ltd.’s upcoming earnings report date?

Consun Pharmaceutical Group Ltd.’s upcoming earnings report date is Aug 19, 2025 which is in 10 days.

How were Consun Pharmaceutical Group Ltd.’s earnings last quarter?

Consun Pharmaceutical Group Ltd. released its earnings results on Mar 26, 2025. The company reported HK$0.662 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.662.

Is Consun Pharmaceutical Group Ltd. overvalued?

According to Wall Street analysts Consun Pharmaceutical Group Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Consun Pharmaceutical Group Ltd. pay dividends?

Consun Pharmaceutical Group Ltd. pays a Notavailable dividend of HK$0.3 which represents an annual dividend yield of 4.41%. See more information on Consun Pharmaceutical Group Ltd. dividends here

What is Consun Pharmaceutical Group Ltd.’s EPS estimate?

Consun Pharmaceutical Group Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Consun Pharmaceutical Group Ltd. have?

Consun Pharmaceutical Group Ltd. has 852,617,400 shares outstanding.

What happened to Consun Pharmaceutical Group Ltd.’s price movement after its last earnings report?

Consun Pharmaceutical Group Ltd. reported an EPS of HK$0.662 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.684%.

Which hedge fund is a major shareholder of Consun Pharmaceutical Group Ltd.?

Currently, no hedge funds are holding shares in HK:1681

Consun Pharmaceutical Group Ltd. Stock Smart Score

Outperform

Fundamentals

Return on Equity

23.28%

Trailing 12-Months

Asset Growth

10.15%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Consun Pharmaceutical Group Ltd.

Consun Pharmaceutical Group Ltd. (1681) is a China-based pharmaceutical company engaged in the research, development, manufacturing, and marketing of modern Chinese medicines and medical contrast medium products. The company primarily focuses on nephrology, orthopedics, and dermatology sectors, providing a diverse range of therapeutic solutions aimed at addressing specific medical needs. Consun Pharmaceutical is recognized for its innovation in traditional Chinese medicine formulations, integrating modern scientific approaches to enhance efficacy and safety.